Your activity: 60 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Spironolactone reduces mortality in heart failure

Spironolactone reduces mortality in heart failure
Kaplan-Meier analysis of survival among 1663 patients with advanced heart failure in the RALES trial shows that spironolactone reduces mortality by 30 percent (35 versus 46 percent for placebo, p<0.001).
Data from: Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709.
Graphic 76232 Version 3.0